Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,576 | 12,059 | 12,624 | 13,597 | 11,339 |
| Receivables | 3,191 | 2,905 | 2,512 | 2,420 | 2,023 |
| Inventories | 600 | 642 | 532 | 445 | 493 |
| Other current assets | 34 | 36 | 39 | 44 | 37 |
| TOTAL | $15,536 | $15,931 | $16,231 | $17,238 | $14,038 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 113 | 129 | 145 | 281 | 116 |
| TOTAL | $113 | $129 | $145 | $281 | $116 |
| Total Assets | $15,649 | $16,060 | $16,376 | $17,519 | $14,154 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,916 | 3,588 | 2,781 | 2,341 | 2,188 |
| Accrued Expenses | 3,259 | 2,969 | 2,609 | 2,979 | 2,578 |
| TOTAL | $12,241 | $11,621 | $10,452 | $10,380 | $9,766 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 46 | 65 | 83 | 101 | 0 |
| TOTAL | $46 | $65 | $83 | $101 | $N/A |
| Total Liabilities | $12,287 | $11,686 | $10,535 | $10,481 | $9,766 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,722 | 1,558 | 1,493 | 1,493 | 1,486 |
| Retained earnings | -132,825 | -131,669 | -130,098 | -128,792 | -127,599 |
| TOTAL | $3,362 | $4,375 | $5,841 | $7,038 | $4,387 |
| Total Liabilities And Equity | $15,649 | $16,060 | $16,376 | $17,519 | $14,154 |